This information reflects public disclosures current as of April , 2016

Recro's product pipeline will change over time as the products move through the drug development process. This description contains forward-looking statements that involve significant risks and uncertainties, including those discussed in Recro's most recent Form 10-K and in Recro's periodic reports on Form 10-Q and Form 8-K, and actual results may vary materially. Recro is providing this information as of the date above and does not undertake any obligation to update any forward-looking statements contained in this table as a result of new information, future events or otherwise.